Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Biochem Biophys Res Commun
; 443(3): 828-33, 2014 Jan 17.
Article
em En
| MEDLINE
| ID: mdl-24342619
Palavras-chave
CD; CRP; DPP-4; Diabetic nephropathy; Dipeptidyl peptidase-4 inhibitor; GIP; GLP-1; ICAM-1; IL; Inflammation; Macrophage; NF-κB; PAM; SD; SpragueDawley; TGF-ß; TNF-α; c-reactive protein; cAMP; cluster of differentiation; cyclic AMP; dipeptidyl peptidase-4; gastric inhibitory polypeptide; glucagon-like peptide-1; intercellular adhesion molecule-1; interleukin; nuclear factor-κB; periodic acid-methenamine silver; transforming growth factor-ß; tumor necrosis factor-α
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Experimental
/
Diabetes Mellitus Tipo 1
/
Inibidores da Dipeptidil Peptidase IV
/
Nefropatias
/
Anti-Inflamatórios
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Biochem Biophys Res Commun
Ano de publicação:
2014
Tipo de documento:
Article